Cynthia R. Cherry

622 total citations
20 papers, 439 citations indexed

About

Cynthia R. Cherry is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Cynthia R. Cherry has authored 20 papers receiving a total of 439 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 6 papers in Pulmonary and Respiratory Medicine and 3 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Cynthia R. Cherry's work include Cancer Immunotherapy and Biomarkers (12 papers), Lung Cancer Research Studies (5 papers) and Colorectal Cancer Treatments and Studies (4 papers). Cynthia R. Cherry is often cited by papers focused on Cancer Immunotherapy and Biomarkers (12 papers), Lung Cancer Research Studies (5 papers) and Colorectal Cancer Treatments and Studies (4 papers). Cynthia R. Cherry collaborates with scholars based in United States, Italy and Japan. Cynthia R. Cherry's co-authors include Paul R. Walker, Abdul Rafeh Naqash, Nitika Sharma, Aparna Hegde, Jessica Hardin, Teresa Parent, Mahvish Muzaffar, Rita Chiari, Shunichi Sugawara and Andrea De Giglio and has published in prestigious journals such as Journal of Clinical Oncology, Journal of the American College of Cardiology and Journal of Thoracic Oncology.

In The Last Decade

Cynthia R. Cherry

20 papers receiving 436 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Cynthia R. Cherry United States	7	386	159	75	37	35	20	439
Maria Silvia Cona Italy	8	279 0.7×	90 0.6×	47 0.6×	80 2.2×	12 0.3×	29	357
Yan-Ping Mao China	2	364 0.9×	125 0.8×	94 1.3×	34 0.9×	25 0.7×	2	417
Seigo Sasaki Japan	4	289 0.7×	153 1.0×	47 0.6×	29 0.8×	32 0.9×	8	326
Amelia Sawyers United States	5	259 0.7×	66 0.4×	49 0.7×	45 1.2×	43 1.2×	8	316
Anne Laure Voisin France	2	271 0.7×	103 0.6×	46 0.6×	24 0.6×	24 0.7×	2	295
Suheil Albert Atallah‐Yunes United States	8	172 0.4×	28 0.2×	82 1.1×	42 1.1×	19 0.5×	22	305
Sandipkumar Patel United States	7	190 0.5×	55 0.3×	45 0.6×	24 0.6×	42 1.2×	20	249
Makiko Yomota Japan	11	172 0.4×	206 1.3×	20 0.3×	30 0.8×	23 0.7×	39	302
Idoia Morilla Spain	10	359 0.9×	129 0.8×	181 2.4×	42 1.1×	10 0.3×	18	464
Elizabeth Panora United States	5	339 0.9×	165 1.0×	52 0.7×	40 1.1×	13 0.4×	7	388

Countries citing papers authored by Cynthia R. Cherry

Since Specialization

Citations

This map shows the geographic impact of Cynthia R. Cherry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cynthia R. Cherry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cynthia R. Cherry more than expected).

Fields of papers citing papers by Cynthia R. Cherry

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cynthia R. Cherry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cynthia R. Cherry. The network helps show where Cynthia R. Cherry may publish in the future.

Co-authorship network of co-authors of Cynthia R. Cherry

This figure shows the co-authorship network connecting the top 25 collaborators of Cynthia R. Cherry. A scholar is included among the top collaborators of Cynthia R. Cherry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cynthia R. Cherry. Cynthia R. Cherry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sehgal, Kartik, Anushi Bulumulle, Ritu R. Gill, et al.. (2020). Association of Extended Dosing Intervals or Delays in Pembrolizumab-based Regimens With Survival Outcomes in Advanced Non–small-cell Lung Cancer. Clinical Lung Cancer. 22(3). e379–e389. 18 indexed citations

Bulumulle, Anushi, et al.. (2020). The real-world incidence of immunotherapy-related thyroid dysfunction: A retrospective analysis of a single center's experience over five years.. Journal of Clinical Oncology. 38(5_suppl). 98–98. 7 indexed citations

Naqash, Abdul Rafeh, Biagio Ricciuti, Dwight H. Owen, et al.. (2020). Outcomes associated with immune-related adverse events in metastatic non-small cell lung cancer treated with nivolumab: a pooled exploratory analysis from a global cohort. Cancer Immunology Immunotherapy. 69(7). 1177–1187. 72 indexed citations

Moey, Melissa, Justin McCallen, Kevin O’Brien, et al.. (2020). Characterization of Immune Checkpoint Inhibitor-Related Cardiotoxicity in Lung Cancer Patients From a Rural Setting. JACC CardioOncology. 2(3). 491–502. 32 indexed citations

Naqash, Abdul Rafeh, et al.. (2019). P1.04-60 Impact of Metastatic Location on Survival in Stage-IV Non-Small Cell Lung Cancer (NSCLC) Treated with Immunotherapy. Journal of Thoracic Oncology. 14(10). S464–S464. 1 indexed citations

Moey, Melissa, et al.. (2019). CHARACTERIZATION OF IMMUNE CHECKPOINT INHIBITOR-RELATED CARDIOTOXICITY IN LUNG CANCER PATIENTS FROM A RURAL SETTING IN EASTERN NORTH CAROLINA. Journal of the American College of Cardiology. 73(9). 972–972. 1 indexed citations

Naqash, Abdul Rafeh, Cynthia R. Cherry, Nitika Sharma, et al.. (2018). Evaluating the utility of pretreatment C-reactive protein (CRP) in survival stratification of advanced non-small cell lung cancer (NSCLC) treated with immune checkpoint blockade (ICB): A prospective cohort study.. Journal of Clinical Oncology. 36(15_suppl). e15122–e15122. 2 indexed citations

Hegde, Aparna, et al.. (2018). Antibiotic use and overall survival in lung cancer patients receiving nivolumab.. Journal of Clinical Oncology. 36(15_suppl). e15109–e15109. 20 indexed citations

Hegde, Aparna, Cynthia R. Cherry, Ramya Pinnamaneni, et al.. (2018). Outcomes of immunomodulatory radiation strategies in combination with nivolumab compared with single agent nivolumab in lung cancer patients.. Journal of Clinical Oncology. 36(15_suppl). e21134–e21134. 5 indexed citations

10.

Sharma, Nitika, Paul R. Walker, Cynthia R. Cherry, et al.. (2017). Immune related adverse events (irAEs): A unique profile based on tumor type.. Journal of Clinical Oncology. 35(15_suppl). e14606–e14606. 1 indexed citations

11.

Naqash, Abdul Rafeh, et al.. (2017). 4A.03 Predictive Utility of c-reactive Protein (CRP) in Advanced Stage Lung Cancer Treated with Anti-Programmed Cell Death-1 (PD-1) Therapy. Journal of Thoracic Oncology. 12(11). S1559–S1559. 1 indexed citations

12.

Pinnamaneni, Ramya, Aparna Hegde, Hyder Arastu, et al.. (2017). Sequence of stereotactic ablative radiotherapy and immune checkpoint blockade in the treatment of metastatic lung cancer.. Journal of Clinical Oncology. 35(15_suppl). e20665–e20665. 5 indexed citations

13.

Hegde, Aparna, Abdul Rafeh Naqash, Cynthia R. Cherry, et al.. (2017). OA03.05 Tocilizumab for the Management of Immune Mediated Adverse Events Secondary to PD-1 Blockade: Overall Survival Analysis. Journal of Thoracic Oncology. 12(11). S1554–S1555. 1 indexed citations

14.

Hegde, Aparna, et al.. (2017). Incidence and impact of thromboembolic events in lung cancer patients treated with nivolumab.. Journal of Clinical Oncology. 35(15_suppl). e20624–e20624. 8 indexed citations

15.

Hegde, Aparna, Cynthia R. Cherry, Abdul Rafeh Naqash, et al.. (2017). Tocilizumab for the management of immune mediated adverse events secondary to PD-1 blockade. Journal of Oncology Pharmacy Practice. 25(3). 551–557. 243 indexed citations

16.

Cherry, Cynthia R., et al.. (2017). Outcomes with immune checkpoint inhibitor use in lung cancer patients with hepatic metastases.. Journal of Clinical Oncology. 35(7_suppl). 38–38. 3 indexed citations

17.

Cherry, Cynthia R., Abdul Rafeh Naqash, Nitika Sharma, et al.. (2017). Tocilizumab for the management of immune mediated adverse events secondary to PD-1 blockade.. Journal of Clinical Oncology. 35(15_suppl). e21712–e21712. 6 indexed citations

18.

Sharma, Nitika, et al.. (2016). Systemic inflammatory response syndrome (SIRS) with immune checkpoint inhibitors.. Journal of Clinical Oncology. 34(15_suppl). 3061–3061. 4 indexed citations

19.

Cherry, Cynthia R., et al.. (2003). Student Affairs as Change Agents. NASPA Journal. 40(2). 29–42. 5 indexed citations

20.

Cherry, Cynthia R., et al.. (2003). Student Affairs as Change Agents. NASPA Journal. 40(2). 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact